Cargando…

Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM)

SIMPLE SUMMARY: Glioblastoma multiforme is one of the hardest-to-treat brain tumors, often resistant to conventional treatments such as chemotherapy and radiation therapy. Despite advances in cancer research and treatment, the survival rate for glioblastoma patients remains low, with most patients o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yalamarty, Satya Siva Kishan, Filipczak, Nina, Li, Xiang, Subhan, Md Abdus, Parveen, Farzana, Ataide, Janaína Artem, Rajmalani, Bharat Ashok, Torchilin, Vladimir P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093719/ https://www.ncbi.nlm.nih.gov/pubmed/37046777 http://dx.doi.org/10.3390/cancers15072116

Ejemplares similares

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
por: Subhan, Md Abdus, et al.
Publicado: (2021)

Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases
por: Filipczak, Nina, et al.
Publicado: (2021)

Lipid-Based Drug Delivery Systems in Regenerative Medicine
por: Filipczak, Nina, et al.
Publicado: (2021)

Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2022)

Co-Encapsulation of Drugs for Topical Application—A Review
por: Ataide, Janaína Artem, et al.
Publicado: (2023)

Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Nano Silver-Induced Toxicity and Associated Mechanisms
por: Zhang, Jing, et al.
Publicado: (2022)

Using Light for Therapy of Glioblastoma Multiforme (GBM)
por: Vasilev, Alex, et al.
Publicado: (2020)

FAM72, Glioblastoma Multiforme (GBM) and Beyond
por: Ho, Nguyen Thi Thanh, et al.
Publicado: (2021)

Role and Therapeutic Targeting Strategies of Neutrophil Extracellular Traps in Inflammation
por: Li, Xiang, et al.
Publicado: (2023)

Migration-Associated Transportome and Therapeutic Potential in Glioblastoma Multiforme (GBM)
por: Vaid, Samir, et al.
Publicado: (2023)

Establishment and Biological Characterization of a Panel of Glioblastoma Multiforme (GBM) and GBM Variant Oncosphere Cell Lines
por: Binder, Zev A., et al.
Publicado: (2016)

DecisionDx-GBM Gene Expression Assay for Prognostic Testing in Glioblastoma Multiform
por: Allingham-Hawkins, Diane, et al.
Publicado: (2010)

Cluster and Principal Component Analysis of Human Glioblastoma Multiforme (GBM) Tumor Proteome
por: Pooladi, Mehdi, et al.
Publicado: (2014)

microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review
por: Makowska, Marianna, et al.
Publicado: (2023)

Ultrastructural characterization of primary cilia in pathologically characterized human glioblastoma multiforme (GBM) tumors
por: Moser, Joanna J, et al.
Publicado: (2014)

Surprisal Analysis of Glioblastoma Multiform (GBM) MicroRNA Dynamics Unveils Tumor Specific Phenotype
por: Zadran, Sohila, et al.
Publicado: (2014)

The effect of silver nanoparticles (AgNPs) on proliferation and apoptosis of in ovo cultured glioblastoma multiforme (GBM) cells
por: Urbańska, Kaja, et al.
Publicado: (2015)

Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM)
por: Amer, Rehab G., et al.
Publicado: (2022)

Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Saponin 1 Induces Apoptosis and Suppresses NF-κB-Mediated Survival Signaling in Glioblastoma Multiforme (GBM)
por: Li, Juan, et al.
Publicado: (2013)

Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice In Vivo
por: Huang, Yi-Ping, et al.
Publicado: (2021)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Correction: Saponin 1 Induces Apoptosis and Suppresses NF-κB-Mediated Survival Signaling in Glioblastoma Multiforme (GBM)
por: Li, Juan, et al.
Publicado: (2014)

Investigation of Eutectic Mixtures of Fatty Acids as a Novel Construct for Temperature-Responsive Drug Delivery
por: Parveen, Farzana, et al.
Publicado: (2022)

Cerebellar giant cell glioblastoma multiforme in an adult
por: Mishra, Sudhansu Sekhar, et al.
Publicado: (2014)

New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab
por: Moustakas, Argirios, et al.
Publicado: (2010)

Intraventricular glioblastoma multiforme mimicking meningioma and review of the literature
por: Patnaik, Ashis, et al.
Publicado: (2017)

GSK461364A, a Polo-Like Kinase-1 Inhibitor Encapsulated in Polymeric Nanoparticles for the Treatment of Glioblastoma Multiforme (GBM)
por: Velpurisiva, Praveena, et al.
Publicado: (2018)

A Multi-Site Phase I Trial of Veliparib with Standard Radiation and Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)
por: Kleinberg, Lawrence, et al.
Publicado: (2023)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Dramatic clinical response in the treatment of small cell glioblastoma multiforme
por: Zaman, Farzana Yasmin, et al.
Publicado: (2022)

Mitochondrial DNA Alterations in Glioblastoma (GBM)
por: Leão Barros, Mariceli Baia, et al.
Publicado: (2021)

Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
por: Valtorta, Silvia, et al.
Publicado: (2017)

Predictive value of tumor recurrence using urinary vascular endothelial factor levels in patients receiving radiation therapy for Glioblastoma Multiforme (GBM)
por: Krauze, Andra V, et al.
Publicado: (2013)

Polymeric Co-Delivery Systems in Cancer Treatment: An Overview on Component Drugs’ Dosage Ratio Effect
por: Pan, Jiayi, et al.
Publicado: (2019)

Treating Glioblastoma Multiforme (GBM) with super hyperfractionated radiation therapy: Implication of temporal dose fractionation optimization including cancer stem cell dynamics
por: Yu, Victoria Y., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ifr9gfqkb70m992ndiovo8ca9